Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: Protocol of a randomized controlled trial

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  van der Spek, Nadia ^a   Vos, Joël ^b,c   van Uden Kraan, Cornelia F ^a,d   Breitbart, William ^e   Cuijpers, Pim ^a   Knipscheer Kuipers, Kitty ^f   Willemsen, Vincent ^f   Tollenaar, Rob A E M ^c   van Asperen, Christi J ^c   Verdonck de Leeuw, Irma M ^a,d  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UNIVERSITY OF ROEHAMPTON   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f Center for psychological care for cancer patients   (Netherlands)

Author keywords

Cancer; Cost effectiveness; Effectiveness; Existential distress; Group psychotherapy; Meaning; Psycho oncology; Survivorship

Indexed keywords

ADJUSTMENT; ALIENATION; ANXIETY DISORDER; ARTICLE; CANCER SURVIVOR; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DISTRESS SYNDROME; EMOTION; EVALUATION STUDY; EVIDENCE BASED PRACTICE; FOLLOW UP; GROUP THERAPY; HOPELESSNESS; HUMAN; LONELINESS; MAJOR CLINICAL STUDY; NETHERLANDS; OPTIMISM; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PEER GROUP; PERSONAL EXPERIENCE; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCREENING; ADAPTIVE BEHAVIOR; ANXIETY; COST BENEFIT ANALYSIS; ECONOMICS; METHODOLOGY; NEOPLASM; PROCEDURES; PSYCHOLOGY; SURVIVOR; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ANXIETY; COST-BENEFIT ANALYSIS; EMOTIONS; HUMANS; NEOPLASMS; NETHERLANDS; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; RESEARCH DESIGN; SURVIVORS; TREATMENT OUTCOME;

EID: 84896733643     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-22     Document Type: Article

References (47)

1. Brenner H. Long-term survival rates of cancer patients achieved by the end of 20th century: a period analysis. Lancet 2002, 360:1131-1135. 10.1016/S0140-6736(02)11199-8, 12387961.
2. Richards M, Stockton D, Bapp P, Coleman MP. How many deaths have been avoided through improvements in cancer survival?. Brit Med Journal 2000, 320:895-898.
3. Lee V. The existential plight of cancer: meaning making as a concrete approach to the intangible search for meaning. Support Care Cancer 2008, 16:779-785. 10.1007/s00520-007-0396-7, 18197427.
4. Tomich PL, Helgeson VS. Five years later: a cross-sectional comparison of breast cancer survivors with healthy women. Psychooncology 2002, 11:154-169. 10.1002/pon.570, 11921331.
5. Zika S, Chaimberlain K. On the relation between meaning in life and well-being. Br J Psychol 1992, 83:133-145. 10.1111/j.2044-8295.1992.tb02429.x, 1559144.
6. Debats DL. Meaning in life: clinical relevance and predictive power. Brit J of Clin Psychol 1996, 35:503-516.
7. Park CL, Edomondson D, Fenster JR, Blank TO. Meaning making and psychological adjustment following cancer: the mediating roles of growth, life meaning, and restored just-world beliefs. Cons and Clin Psy 2008, 76:863-875.
8. Lee V, Cohen SR, Edgar L, Laizner AM, Gagnon AJ. Meaning-making intervention during breast or colorectal cancer treatment improves self-esteem, optimism, and self-efficacy. Soc Sci Med 2006, 62:3133-3145. 10.1016/j.socscimed.2005.11.041, 16413644.
9. Chochinov HM, Hack TF, Hassard T, Kristjanson LJ, McClement S, Harlos M. Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life. J Clin Oncol 2005, 23:5520-5525. 10.1200/JCO.2005.08.391, 16110012.
10. Giese-Davis J, Koopman C, Butler LD, Classen C, Cordova M, Fobair D, Benson J, Kraemer HC, Spiegel D. Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy. Cons and Clin Psy 2002, 70:916-925.
11. Breitbart W, Rosenfeld B, Gibson C, Pessin H, Poppito S, Nelson C, Tomarken A, Kosinski Timm A, Berg A, Jacobson C, Sorger B, Abbey J, Olden M. Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial. Psychooncology 2010, 19:21-28. 10.1002/pon.1556, 3648880, 19274623.
12. Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-Davis J, Fobair P, Carlson RW, Kraemer HC, Spiegel D. Supportive-expressive group therapy and distress in patients with metastatic breast cancer. Arch of Gen Psychiatry 2001, 28:494-501.
13. Spiegel D, Spira J. Supportive-Expressive Group Therapy: A Treatment Manual of Psychosocial Intervention for Women with Recurrent Breast Cancer 1991, Stanford, CA: Stanford University School of Medicine.
14. Kissane DW, Bloch S, Smith GC, Miach P, Clarke DM, Ikin J, Love A, Ranieri N, McKenzie D. Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. Psychooncology 2003, 12:532-546. 10.1002/pon.683, 12923794.
15. Coward DD. Facilitation of self-transcendence in a breast cancer support group: II. Onc Nurs Forum 2003, 30:291-300.
16. LeMay K, Wilson KG. Treatment of existential distress in life threatening illness: a review of manualized interventions. Clin Psychol Rev 2008, 28:472-493. 10.1016/j.cpr.2007.07.013, 17804130.
17. Linn M, Linn B, Harris R. Effects of counseling for late-stage cancer patients. Cancer 1982, 49:1048-1055. 10.1002/1097-0142(19820301)49:5<1048::AID-CNCR2820490534>3.0.CO;2-G, 7059922.
18. Breitbart W. Spirituality and meaning in supportive care: spirituality- and meaning-centered group psychotherapy interventions in advanced cancer. Support Care Cancer 2002, 10:272-280. 10.1007/s005200100289, 12029426.
19. Frankl V. The doctor and the soul. From Psychotherapy to Logotherapy 1986, London: Random House.
20. Frankl V. The Will to Meaning: Foundations and Applications of Logotherapy, ed. L 1989, New York: New American.
21. Frankl V. Man's Search for Meaning: An Introduction to Logotherapy 1998, London: British paperback edition: random House.
22. Van der Spek N, Vos J, Van Uden-Kraan CF, Breitbart W, Tollenaar RAEM, Cuijpers P, Verdonck-de Leeuw IM. Meaning making in cancer survivors: a focus group study. PLoS One 2013, 8:1-7.
23. Van der Spek N, Van Uden-Kraan CF, Vos J, Breitbart W, Tollenaar RAEM, Van Asperen CJ, Cuijpers P, Verdonck-de Leeuw IM. Meaning-Centered Group Psychotherapy in Cancer Survivors: a Feasibility Study. Psychooncology 2014, DOI: 10.1002/pon.3497 [E pub ahead of print].
24. Payne DK, Vroom P, Phil M. Supportive Group Psychotherapy: A Group Intervention for Cancer Patients 2009, Memorial Sloan-Kettering Cancer Center: New York.
25. Jaarsma TA, Pool G, Ranchor AV, Sanderman R. The concept and measurement of meaning in life in Dutch cancer patients. Psychooncology 2007, 16:241-248. 10.1002/pon.1056, 16850389.
26. Jaarsma TA, Pool G. Posttraumatic Growth Inventory: Dutch Version 2003, Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken.
27. Dierendonck D. The construct validity of Ryff's scales of psychological well-being and its extension with spiritual well-being. Pers Individ Dif 2005, 36:629-643.
28. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376. 10.1093/jnci/85.5.365, 8433390.
29. Fayers P, Bottomley A. Quality of life research within the EORTC-the EORTC QLQ - C30, European Organisation for Research and Treatment of Cancer. Eur J Cancer 2002, 38:125-133.
30. Spinhoven P. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997, 27:363-370. 10.1017/S0033291796004382, 9089829.
31. Young MA, Halper IS, Clark DS, Scheftner W, Fawcett J. An item-response theory evaluation of the Beck Hopelessness Scale. Cog Ther Res 1992, 16:579-587.
32. Beck AT, Weissman A, Lester D, Trexler L. Measurement of pessismism- hopelessness scale. Cons and Clin Psy 1974, 42:861-865.
33. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem) - a reevaluation of the life orientation test. J Pers Soc Psychol 1994, 67:1063-1078.
34. ten Klooster PM, Weekers AM, Eggelmeijer F, Van Woerkom JM, Drossaert CHCM, Taal E, Rasker JJ, Baneke JJ. Optimisme en/of pessimisme: factorstructuur van de Nederlandse Life Orientation Test-Revised. Psychologie en Gezondheid 2010, 38:89-100.
35. Van Roijen L, Van Straten A, Maiwenn AL, Rutten F, Donker M. Cost-utility of brief psychological treatment for depression and anxiety. Br J Psychiatry 2006, 188:323-329. 10.1192/bjp.188.4.323, 16582058.
36. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA. Manual for Costing: Methods and Standard Costs for Economic Evaluations in Health Care 2004, Diemen: Health Insurance Board.
37. Brooks R. EuroQol: the current state of play. Health Pol 1996, 37:53-72.
38. Koopmanschap MA. PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies. Expert Rev Pharmacoecon Outcomes Res 2005, 5:23-28. 10.1586/14737167.5.1.23, 19807557.
39. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008, 40:879-889. 10.3758/BRM.40.3.879, 18697684.
40. Kraemer HC, Wilson T, Fairburn CG, Phil M, Agras S. Mediators and moderators of treatment effects in randomized clinical trials. Arch of Gen Psychiatry 2002, 59:877-883.
41. Oostenbrink JB. Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 2002, 20:443-454. 10.2165/00019053-200220070-00002, 12093300.
42. Langley PC. The November 1995 revised Australian guidelines for the economic evaluation of pharmaceuticals. Pharmacoeconomics 1996, 9:341-352. 10.2165/00019053-199609040-00007, 10160108.
43. Torrance GW, Blaker D, Detsky A, Kennedy W, Schubert F, Menon D, Tugwell P, Konchak R, Hubbard E, Fireston T. Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics. Pharmacoeconomics 1996, 9:535-559. 10.2165/00019053-199609060-00008, 10160481.
44. Brouwer WB, Koopmanschap MA, Rutten FF. Productivity losses without absence: measurement validation and empirical evidence. Health Pol 1999, 48:13-27.
45. Van Hout BA, Maiwenn JA, Gordon GS, Rutten FFH. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 1994, 3:309-319. 10.1002/hec.4730030505, 7827647.
46. Thompson SC, Pitts J. Factors relating to a person's ability to find meaning after a diagnosis of cancer. J Psychosoc Oncol 1994, 11:1-21.
47. Gottlieb BH, Wachala ED. Cancer support groups: a critical review of empirical studies. Psychooncology 2006, 16:379-400.